Beckman Coulter suffers shares slump after uninspiring Q2
This article was originally published in Clinica
A day after the firm released disappointing second-quarter results, Beckman Coulter’s shares fell to their lowest price in more than a year. On 23 June, the company’s shares dropped to $45.23, their poorest showing since March 2009. The day before, Beckman’s shares were trading at $61 each.